Published by linker 5
Posted on February 5, 2021
3 min readLast updated: January 21, 2026
FMI states in its recent study on the acute kidney injury treatment that the market will record a noteworthy CAGR of 8% through 2029. Demand for acute kidney injury is anticipated to continue surging particularly due to the increased global burden of acute kidney injury among people.
“hospitals are likely to strengthen their grip on market revenue in the near term, as governments in numerous countries are developing various platforms by creating more treatment options.” says the FMI analyst.
Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-9399
Acute kidney injury Market – Important Highlights
Acute kidney injury Market – Drivers
For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-9399
Acute kidney injury Market – Restraints
COVID-19 Impact on Acute kidney injury Market
The acute kidney injury market growth is expected to be hampered owing to the unprecedented COVID-19 pandemic. As several countries went into lockdown, frequent visits to the hospital got reduced by the patients and the main focus of the doctors shifted to bring this pandemic under control. However, the market is expected to experience a swift turnaround with the stabilization of the economy.
Competitive Landscape
The acute kidney injury market players are leaning towards the expansion of the production facilities besides opting for strategic collaborations to attain a competitive edge.
A few of the key companies functioning in the global market include Braun Melsungen, Baxter International, Inc., Asahi Kasei Medical Co., Ltd, Baxter International, Inc.
Explore more articles in the Research Reports category
